Global Genome Editing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Genome Editing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Technology (Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc Finger Nuclease (ZFN), and Other Technologies), Application (Cell Line Editing, Animal Genome Editing, Plant Genome Editing, and Others), End-user (Pharmaceutical companies and Biotechnology Companies, Academics and Government Research Institutes, and Clinical Research Organizations), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Genome Editing Market was valued at USD 7,529.1 million in 2023 and is expected to reach USD 27,919.2 million by 2031 while growing at a CAGR of 17.8% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global genome editing market growth. Genome editing, a groundbreaking technology, empowers scientists to precisely modify the DNA (deoxyribonucleic acid) of living organisms. This genetic material contains instructions for the development, functioning, growth, and reTechnologyion of all living entities. With genome editing techniques, researchers can add, delete, or modify specific DNA sequences within an organism's genome.
Advancements in CRISPR technology and a rising incidence of genetic disorders are driving the growth of the genome editing market. However, obstacles such as ethical and regulatory concerns, along with delivery challenges, may impede market expansion.
Furthermore, the global genome editing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Genome Editing Market is segmented among Clustered regularly interspaced short palindromic repeats (CRISPR), Transcription activator-like effector nuclease (TALEN), Zinc Finger Nuclease (ZFN), and Other Technologies, based on Technology. In 2023, Clustered regularly interspaced short palindromic repeats (CRISPR) accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Genome Editing Market is segmented among Cell Line Editing, Animal Genome Editing, Plant Genome Editing, and Others, based on Application. In 2023, Animal Genome Editing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Genome Editing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Editas Medicine, GenScript USA Inc., Horizon Discovery Group plc, Integrated DNA Technologies Inc., Lonza Group Ltd, Merck & Co., New England Biolabs Inc., Origene Technologies Inc., Sangamo Biosciences Inc., and Takara Bio Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Genome Editing Market Dynamics
Drivers
Restraints
Opportunity
4. Global Genome Editing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Genome Editing Market Segmentation, By Technology
Global Genome Editing Market Share Analysis, By Technology
Global Genome Editing Market Growth Analysis, By Technology
Global Genome Editing Market Trends, By Technology
o Clustered regularly interspaced short palindromic repeats (CRISPR)
o Transcription activator-like effector nuclease (TALEN)
o Zinc Finger Nuclease (ZFN)
o Other Technologies
6. Global Genome Editing Market Segmentation, By Application
Global Genome Editing Market Share Analysis, By Application
Global Genome Editing Market Growth Analysis, By Application
Global Genome Editing Market Trends, By Application
o Cell Line Editing
o Animal Genome Editing
o Plant Genome Editing
o Others
7. Global Genome Editing Market Segmentation, By End-user
Global Genome Editing Market Share Analysis, By End-user
Global Genome Editing Market Growth Analysis, By End-user
Global Genome Editing Market Trends, By End-user
o Pharmaceutical companies and Biotechnology Companies
o Academics and Government Research Institutes
o Clinical Research Organizations
8. Global Genome Editing Market Segmentation, By Region
Global Genome Editing Market Share Analysis, By Region
Global Genome Editing Market Growth Analysis, By Region
Global Genome Editing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Editas Medicine*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
GenScript USA Inc.
Horizon Discovery Group plc
Integrated DNA Technologies Inc.
Lonza Group Ltd
Merck & Co.
New England Biolabs Inc.
Origene Technologies Inc.
Sangamo Biosciences Inc.
Takara Bio Inc.
*Similar analysis will be provided for each company listed above.
